Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Pathophysiology, Diagnosis, and New and Emerging Treatment Options
FcRn Inhibition for the Treatment of Generalized Myasthenia Gravis (gMG): Patient Selection, Tailoring Dosing Regimens, Updated Disease Management Paradigms
LIVE UPDATE FROM AHA24: What do we know about antiplatelets added to anticoagulation in patients with AF?
Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN